Santen Pharmaceutical Co. will receive the Glaucoma Research Foundation’s Catalyst Award, the organization’s highest distinction.
Santen Pharmaceutical Co. will receive the Glaucoma Research Foundation’s Catalyst Award, the organization’s highest distinction.